BioLife Solutions Total Assets 2011-2025 | BLFS
BioLife Solutions total assets from 2011 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
|
BioLife Solutions Annual Total Assets (Millions of US $) |
|
|---|---|
| 2024 | $399 |
| 2023 | $413 |
| 2022 | $450 |
| 2021 | $554 |
| 2020 | $235 |
| 2019 | $93 |
| 2018 | $45 |
| 2017 | $12 |
| 2016 | $8 |
| 2015 | $12 |
| 2014 | $16 |
| 2013 | $3 |
| 2012 | $3 |
| 2011 | $2 |
| 2010 | $1 |
|
BioLife Solutions Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2025-06-30 | $387 |
| 2025-03-31 | $395 |
| 2024-12-31 | $399 |
| 2024-09-30 | $382 |
| 2024-06-30 | $375 |
| 2024-03-31 | $402 |
| 2023-12-31 | $413 |
| 2023-09-30 | $411 |
| 2023-06-30 | $433 |
| 2023-03-31 | $446 |
| 2022-12-31 | $450 |
| 2022-09-30 | $488 |
| 2022-06-30 | $470 |
| 2022-03-31 | $544 |
| 2021-12-31 | $554 |
| 2021-09-30 | $559 |
| 2021-06-30 | $521 |
| 2021-03-31 | $240 |
| 2020-12-31 | $235 |
| 2020-09-30 | $196 |
| 2020-06-30 | $114 |
| 2020-03-31 | $95 |
| 2019-12-31 | $93 |
| 2019-09-30 | $84 |
| 2019-06-30 | $52 |
| 2019-03-31 | $48 |
| 2018-12-31 | $45 |
| 2018-09-30 | $46 |
| 2018-06-30 | $22 |
| 2018-03-31 | $12 |
| 2017-12-31 | $12 |
| 2017-09-30 | $9 |
| 2017-06-30 | $8 |
| 2017-03-31 | $9 |
| 2016-12-31 | $8 |
| 2016-09-30 | $11 |
| 2016-06-30 | $11 |
| 2016-03-31 | $11 |
| 2015-12-31 | $12 |
| 2015-09-30 | $13 |
| 2015-06-30 | $14 |
| 2015-03-31 | $15 |
| 2014-12-31 | $16 |
| 2014-09-30 | $14 |
| 2014-06-30 | $15 |
| 2014-03-31 | $16 |
| 2013-12-31 | $3 |
| 2013-09-30 | $3 |
| 2013-06-30 | $3 |
| 2013-03-31 | $3 |
| 2012-12-31 | $3 |
| 2012-09-30 | $3 |
| 2012-06-30 | $3 |
| 2012-03-31 | $2 |
| 2011-12-31 | $2 |
| 2011-09-30 | $2 |
| 2011-06-30 | $1 |
| 2011-03-31 | $1 |
| 2010-12-31 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.294B | $0.082B |
| BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $217.272B | 25.04 |
| EssilorLuxottica (ESLOY) | France | $167.297B | 0.00 |
| Boston Scientific (BSX) | United States | $146.836B | 33.58 |
| Stryker (SYK) | United States | $135.305B | 26.86 |
| Medtronic (MDT) | Ireland | $115.519B | 16.29 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.274B | 0.00 |
| Agilent Technologies (A) | United States | $41.813B | 27.06 |
| ResMed (RMD) | United States | $36.434B | 25.22 |
| GE HealthCare Technologies (GEHC) | United States | $33.786B | 16.16 |
| Koninklijke Philips (PHG) | Netherlands | $27.193B | 17.76 |
| Terumo (TRUMY) | Japan | $23.733B | 28.12 |
| Insulet (PODD) | United States | $22.765B | 70.61 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.541B | 10.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.850B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.495B | 0.00 |
| Baxter (BAX) | United States | $9.243B | 7.46 |
| Bio-Rad Laboratories (BIO) | United States | $8.296B | 29.73 |
| Demant (WILYY) | Denmark | $7.359B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.651B | 10.85 |
| Haemonetics (HAE) | United States | $3.233B | 13.98 |
| Envista Holdings (NVST) | United States | $3.203B | 18.38 |
| ICU Medical (ICUI) | United States | $3.201B | 20.32 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.020B | 13.46 |
| Perrigo (PRGO) | Ireland | $2.055B | 5.15 |
| LeMaitre Vascular (LMAT) | United States | $1.938B | 39.09 |
| Phibro Animal Health (PAHC) | United States | $1.745B | 17.42 |
| Curaleaf Holdings (CURLF) | Canada | $1.634B | 0.00 |
| AtriCure (ATRC) | United States | $1.566B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.444B | 9.28 |
| Tilray Brands (TLRY) | Canada | $1.359B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.350B | 59.18 |
| Kestra Medical Technologies (KMTS) | United States | $1.343B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.300B | 18.84 |
| Neogen (NEOG) | United States | $1.299B | 24.92 |
| InMode (INMD) | Israel | $0.913B | 10.31 |
| Valneva SE (VALN) | France | $0.765B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.738B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.493B | 16.99 |
| Evolus (EOLS) | United States | $0.465B | 0.00 |
| SNDL (SNDL) | Canada | $0.462B | 0.00 |
| Omeros (OMER) | United States | $0.448B | 0.00 |
| CeriBell (CBLL) | United States | $0.429B | 0.00 |
| Surmodics (SRDX) | United States | $0.378B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.356B | 0.00 |
| Brainsway (BWAY) | Israel | $0.296B | 59.96 |
| Capricor Therapeutics (CAPR) | United States | $0.287B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Cerus (CERS) | United States | $0.270B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.261B | 0.00 |
| High Tide (HITI) | Canada | $0.253B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.248B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.245B | 145.33 |
| Owens & Minor (OMI) | United States | $0.241B | 2.42 |
| Viemed Healthcare (VMD) | United States | $0.238B | 18.97 |
| Exagen (XGN) | United States | $0.235B | 0.00 |
| Quanterix (QTRX) | United States | $0.232B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.226B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.219B | 0.00 |
| Organigram Global (OGI) | Canada | $0.199B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 16.35 |
| TerrAscend (TSNDF) | Canada | $0.181B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.176B | 21.68 |
| OraSure Technologies (OSUR) | United States | $0.172B | 0.00 |
| Biote (BTMD) | United States | $0.140B | 5.68 |
| Apyx Medical (APYX) | United States | $0.127B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.108B | 0.00 |
| Sharps Technology (STSS) | United States | $0.107B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.099B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 12.01 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Agape ATP (ATPC) | $0.062B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.057B | 33.21 |
| Nephros (NEPH) | United States | $0.055B | 40.00 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| Jin Medical (ZJYL) | China | $0.041B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Bonk (BNKK) | United States | $0.033B | 0.00 |
| Zynex (ZYXI) | United States | $0.032B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.26 |
| Modular Medical (MODD) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| INLIF (INLF) | China | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |